Literature DB >> 3013942

Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin.

A I Schafer, A K Maas, J A Ware, P C Johnson, S E Rittenhouse, E W Salzman.   

Abstract

Studies have been performed on the biochemical mechanism of platelet activation induced by the fibrinolytic protease plasmin. In washed human platelets, greater than or equal to 1.0 caseinolytic units (CU/ml plasmin induced aggregation. Platelet [14C]serotonin release was stimulated by 1.0 CU/ml plasmin to an extent comparable to that induced by 1.0 U/ml thrombin. A dose- and time-dependent phosphorylation of the platelet 47,000- and 20,000-kD proteins was noted in 32PO4-labeled platelets incubated with plasmin; phosphorylation was not affected by extracellular Ca2+, but was completely inhibited by an increase in platelet cyclic AMP. Phosphorylation of these platelet proteins suggested that plasmin may act on platelets by stimulating a rise in cytosolic calcium concentration ([Cai2+]) and activating inositol phospholipid-dependent phospholipase C and protein kinase C. Using both quin2 fluorescence and aequorin luminescence as indicators, plasmin was found to elevate platelet [Cai2+] in the presence or absence of extracellular Ca2+. Phospholipase C activation was shown by the generation of [3H]diglyceride in [3H]arachidonic acid-labeled platelets and [32P]phosphatidic acid in 32PO4 labeled platelets exposed to plasmin. Plasmin did not induce formation of thromboxane A2 (TXA2). Only small amounts of this eicosanoid were detected late in the time course after plasmin stimulation. Our results indicate that plasmin causes platelet aggregation and secretion associated with phosphorylation of the 47,000- and 20,000-kD proteins, Ca2+ mobilization, and phospholipase C and protein kinase C activation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013942      PMCID: PMC329533          DOI: 10.1172/JCI112576

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  THE AGGREGATION OF BLOOD PLATELETS.

Authors:  G V BORN; M J CROSS
Journal:  J Physiol       Date:  1963-08       Impact factor: 5.182

2.  Differential activation of platelet phospholipases by thrombin and ionophore A23187.

Authors:  S Rittenhouse-Simmons
Journal:  J Biol Chem       Date:  1981-05-10       Impact factor: 5.157

Review 3.  On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture.

Authors:  D Collen
Journal:  Thromb Haemost       Date:  1980-06-18       Impact factor: 5.249

4.  Platelet aggregation after thrombolytic therapy.

Authors:  P Griguer; M Brochier; J Leroy; M H Leclerc; G Antoine; H Bertrand; F Chalons
Journal:  Angiology       Date:  1980-02       Impact factor: 3.619

5.  Clot retraction facilitates clot lysis.

Authors:  R C Carroll; J M Gerrard; J M Gilliam
Journal:  Blood       Date:  1981-01       Impact factor: 22.113

6.  Plasmin inhibition of thrombin-induced platelet aggregation.

Authors:  J L Miller; A J Katz; M B Feinstein
Journal:  Thromb Diath Haemorrh       Date:  1975-04-30

7.  Production of diglyceride from phosphatidylinositol in activated human platelets.

Authors:  S Rittenhouse-Simmons
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

8.  Role of platelets in lysis of dilute plasma clots: requirement for metabolically active platelets.

Authors:  M S Lockhart; P C Comp; F B Taylor
Journal:  J Lab Clin Med       Date:  1979-08

9.  Cytochalasins inhibit arachidonic acid metabolism in thrombin-stimulated platelets.

Authors:  W Siess; E G Lapetina; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

10.  Plasminogen, plasminogen activator, and platelets in the regulation of clot lysis. Reconstitution and patient studies.

Authors:  R C Carroll; R D Radcliffe; F B Taylor; J M Gerrard
Journal:  J Lab Clin Med       Date:  1982-12
View more
  17 in total

1.  Achieving Optimal Reperfusion without Adjunctive Antithrombotic Therapy: Novel Thrombolytic Dosing Strategies.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

2.  Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism.

Authors:  L H Block; M Knorr; E Vogt; R Locher; W Vetter; P Groscurth; B Y Qiao; D Pometta; R James; M Regenass
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

3.  Alkaline phosphatase prevents platelet stimulation by thromboxane-mimetics.

Authors:  M Hatmi; B Haye; J M Gavaret; B B Vargaftig; C Jacquemin
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

4.  Selective incorporation of (15S)-hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils: agonist-induced deacylation and transformation of stored hydroxyeicosanoids.

Authors:  M E Brezinski; C N Serhan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

5.  Bovine erythrocyte haemolysates enhance plasminogen activation by tissue-type plasminogen activator.

Authors:  M Yamada; T Horiuchi; T Oribe; S Yamamoto; I Sugie; P A Gentry
Journal:  Vet Res Commun       Date:  1997-02       Impact factor: 2.459

6.  Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator.

Authors:  D J Fitzgerald; G A Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

7.  A novel mechanism of plasmin-induced mitogenesis in fibroblasts.

Authors:  S K Mandal; L V M Rao; T T T Tran; U R Pendurthi
Journal:  J Thromb Haemost       Date:  2005-01       Impact factor: 5.824

8.  Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitor.

Authors:  You fu Li; Frederick A Spencer; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2003-02       Impact factor: 2.300

9.  Plasmin modulates the thrombin-evoked calcium response in C6 glioma cells.

Authors:  J S Turner; G T Redpath; J E Humphries; S L Gonias; S R Vandenberg
Journal:  Biochem J       Date:  1994-01-01       Impact factor: 3.857

Review 10.  Thrombolysis in the management of acute myocardial infarction and unstable angina pectoris.

Authors:  J Loscalzo
Journal:  Drugs       Date:  1989-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.